Given our finding that APOBEC3B induced TP53 mutation, we examined the effect of this mutation on proliferation and drug sensitivity of APOBEC3B-expressing Pfeiffer DLBCL cells. Here, APOBEC3B is linked to diffuse large B-cell lymphoma.